Search results
Judgment of the Court of First Instance (Fifth Chamber, extended composition) of 26 October 2000. # Bayer AG v Commission of the European Communities.
Summary of the Judgment 1. Competition — Agreements, decisions and concerted practices — Agreements between undertakings — Meaning — Bilateral or multilateral conduct — Included — Uni lateral conduct — Not included — Conduct appearing unilateral — Need to prove acquiescence by other undertakings in that conduct
View Case T-41/96R, Bayer AG v. Commission of the European Communities, [1996] ECR II-381, Order of 3 June 1996 by - Common Market Law Review.
Bayer AG v Commission of the European Communities. Competition - Parallel imports - Article 85(1) of the EC Treaty (now Article 81(1) EC) - Meaning of "agreement between undertakings" - Proof of the existence of an agreement - Market in pharmaceutical products.
4 sty 2024 · Facts. Bayer made and marketed medical drug intended to treat heart disease. As result of differences between national health authorities of MS, prices of these drugs were different across EU, lower in France and Spain. So Spain and France exported great amounts of drugs to the UK.
29 lis 2018 · Introduction: summary of the claim. The case concerns a judicial review claim by Bayer Plc (“Bayer”) and Novartis Pharmaceuticals UK Ltd (“Novartis”) which challenged the lawfulness of a policy adopted by the defendant Clinical Commissioning Groups (“CCGs”) in Northern England. The policy concerns treatment of Age-Related Macular ...
The Commission held that a tacit agreement existed between Bayer and the wholesalers not to export to the UK contrary to Article 81(1): in its view the agreement was evidenced by the wholesalers ceasing to supply the UK in response to Bayer's tactic of reducing supplies.
